Samuel D. Isaly is the Managing Partner of OrbiMed. Mr. Isaly is one of the world's most recognized healthcare fund managers and has been active in global healthcare investing and analysis since 1968 when he joined Chase Manhattan Bank in New York.
During his career, Mr. Isaly has been a pharmaceutical analyst with Chase Manhattan Bank, Merrill Lynch, Legg Mason, and S. G. Warburg. He launched OrbiMed's asset management business in 1989. He was recently featured in Barron's Magazine (January 9, 2016) as the only United States mutual fund manager to consistently beat the S&P 500 for the 25-year period ending November 30, 2015.
Mr. Isaly has an A.B. in Economics from Princeton University and a M. Sc. (Econ.) from The London School of Economics.